Our mission at Kriya Therapeutics is to expand the reach of gene therapy to address highly prevalent diseases affecting millions of patients.
Location: United States, California, Redwood City
Total raised: $370M
Investors 4
Date | Name | Website |
- | Foresite C... | foresiteca... |
- | T1D Fund | t1dfund.or... |
- | BlueBird V... | bluebirdvc... |
- | Narya | naryavc.co... |
Funding Rounds 2
Date | Series | Amount | Investors |
17.05.2022 | Series C | $270M | - |
16.07.2021 | Series B | $100M | Foresite C... |
Mentions in press and media 11
Date | Title | Description | Source |
20.12.2023 | Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia... | We've launched a new Fierce Biotech Fundraising Tracker for 2023 to track all the venture capital fl... | fiercebiot... |
18.11.2022 | Kriya Acquires Redpin Therapeutics | Kriya, a Redwood City CA, and Research Triangle Park, NC-based gene therapy company, acquired Redpin... | finsmes.co... |
18.05.2022 | What to know about Instacart’s IPO | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
17.05.2022 | Kriya Therapeutics Raises $270M in Series C Financing | Kriya Therapeutics, Inc., a Redwood City, CA and Research Triangle Park, NC-based fully integrated g... | finsmes.co... |
16.05.2022 | Kriya cashes in $270M series C to further finance all-in-one... | Kriya Therapeutics has reeled in a whopping $270 million from its series C round, surpassing the $18... | fiercebiot... |
20.07.2021 | Digital health news, funding roundup in the prior week; July... | With $150B already invested, VC is set to have another recording breaking year With $150B already i... | vator.tv/n... |
15.07.2021 | Kriya Therapeutics lands $100M | Gene therapy startup Kriya Therapeutics has closed a $100 million Series B led by Patient Square Cap... | pitchbook.... |
14.07.2021 | Kriya Therapeutics Completes $100 Million Series B Financing... | Financing led by Patient Square Capital with participation from leading life sciences investors to s... | patientsqu... |
12.02.2021 | George Church and an entrepreneurial postdoc join the h... | In 2018, when Vivek Ramaswamy’s Axovant failed multiple trials on its lead dementia drug and pivoted... | endpts.com... |
12.05.2020 | Kriya Therapeutics Raises $80M in Series A Financing | Kriya Therapeutics, a Palo Alto, Calif. and Durham, N.C.-based gene therapy company, raised $80.5m i... | finsmes.co... |
Show more